Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1965 1
1968 1
1970 1
1971 1
1972 1
1983 2
1984 2
1985 1
1986 1
1987 1
1988 2
1989 4
1990 1
1991 5
1992 1
1993 3
1995 4
1996 2
1997 3
1998 11
1999 7
2000 2
2001 3
2002 6
2003 9
2004 4
2005 9
2006 8
2007 7
2008 13
2009 10
2010 15
2011 16
2012 12
2013 16
2014 19
2015 16
2016 18
2017 14
2018 20
2019 16
2020 12
2021 11
2022 8
Text availability
Article attribute
Article type
Publication date

Search Results

284 results
Results by year
Filters applied: . Clear all
Page 1
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.
Hicks JK, Bishop JR, Sangkuhl K, Müller DJ, Ji Y, Leckband SG, Leeder JS, Graham RL, Chiulli DL, LLerena A, Skaar TC, Scott SA, Stingl JC, Klein TE, Caudle KE, Gaedigk A; Clinical Pharmacogenetics Implementation Consortium. Hicks JK, et al. Among authors: leeder js. Clin Pharmacol Ther. 2015 Aug;98(2):127-34. doi: 10.1002/cpt.147. Epub 2015 Jun 29. Clin Pharmacol Ther. 2015. PMID: 25974703 Free PMC article. Review.
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy.
Crews KR, Monte AA, Huddart R, Caudle KE, Kharasch ED, Gaedigk A, Dunnenberger HM, Leeder JS, Callaghan JT, Samer CF, Klein TE, Haidar CE, Van Driest SL, Ruano G, Sangkuhl K, Cavallari LH, Müller DJ, Prows CA, Nagy M, Somogyi AA, Skaar TC. Crews KR, et al. Among authors: leeder js. Clin Pharmacol Ther. 2021 Oct;110(4):888-896. doi: 10.1002/cpt.2149. Epub 2021 Feb 9. Clin Pharmacol Ther. 2021. PMID: 33387367 Review.
Valproic acid pathway: pharmacokinetics and pharmacodynamics.
Ghodke-Puranik Y, Thorn CF, Lamba JK, Leeder JS, Song W, Birnbaum AK, Altman RB, Klein TE. Ghodke-Puranik Y, et al. Among authors: leeder js. Pharmacogenet Genomics. 2013 Apr;23(4):236-41. doi: 10.1097/FPC.0b013e32835ea0b2. Pharmacogenet Genomics. 2013. PMID: 23407051 Free PMC article. No abstract available.
Aprepitant and fosaprepitant drug interactions: a systematic review.
Patel P, Leeder JS, Piquette-Miller M, Dupuis LL. Patel P, et al. Among authors: leeder js. Br J Clin Pharmacol. 2017 Oct;83(10):2148-2162. doi: 10.1111/bcp.13322. Epub 2017 Jun 10. Br J Clin Pharmacol. 2017. PMID: 28470980 Free PMC article. Review.
Sleep and the athlete: narrative review and 2021 expert consensus recommendations.
Walsh NP, Halson SL, Sargent C, Roach GD, Nédélec M, Gupta L, Leeder J, Fullagar HH, Coutts AJ, Edwards BJ, Pullinger SA, Robertson CM, Burniston JG, Lastella M, Le Meur Y, Hausswirth C, Bender AM, Grandner MA, Samuels CH. Walsh NP, et al. Among authors: leeder j. Br J Sports Med. 2020 Nov 3:bjsports-2020-102025. doi: 10.1136/bjsports-2020-102025. Online ahead of print. Br J Sports Med. 2020. PMID: 33144349
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing.
Birdwell KA, Decker B, Barbarino JM, Peterson JF, Stein CM, Sadee W, Wang D, Vinks AA, He Y, Swen JJ, Leeder JS, van Schaik R, Thummel KE, Klein TE, Caudle KE, MacPhee IA. Birdwell KA, et al. Among authors: leeder js. Clin Pharmacol Ther. 2015 Jul;98(1):19-24. doi: 10.1002/cpt.113. Epub 2015 Jun 3. Clin Pharmacol Ther. 2015. PMID: 25801146 Free PMC article.
Ontogeny of Drug-Metabolizing Enzymes.
Thakur A, Parvez MM, Leeder JS, Prasad B. Thakur A, et al. Among authors: leeder js. Methods Mol Biol. 2021;2342:551-593. doi: 10.1007/978-1-0716-1554-6_18. Methods Mol Biol. 2021. PMID: 34272706 Review.
284 results